Latest News - UPM-Kymmene
Top Corporates Hub
UPM-Kymmene
Philip Morris Raises FX Outlook as IQOS, ZYN Fuel Smoke-Free Growth
09.09.2026 12:02
Philip Morris International (NYSE:PM) Chief Executive Officer Jacek Olczak said the company has revised its full-year guidance solely to reflect foreign-exchange movements, citing a favorable currency impact of about $0.24 at current spot rates. For the third quarter, the company expects a favorable
FDA Authorization Expands Philip Morris’s Zyn Bet, Can It Pay Off?
08.09.2026 00:04
Philip Morris International Inc. (NYSE:PM) has received FDA authorization for 11 nicotine-pouch products, bolstering its position in the fastest-growing nicotine category in the United States. The newly authorized products include higher-strength Zyn Ultra pouches that Philip Morris (NYSE:PM) launched in June at prices below those of its flagship Zyn brand. The strategy could help the […]
British American Tobacco: A Long-Term Perspective On This 6% Yielder
03.09.2026 03:52
British American Tobacco's Modern Oral segment grew 65.9% in H1 '26 and is now the company's largest New Category. Learn why BTI stock is a strong buy.
Altria Group Just Declared Its 61st Dividend Increase in 57 Years. Here's What $10,000 Invested Pays Annually.
02.09.2026 10:20
Altria Group has been able to raise prices in order to generate steady cash flows.
Philip Morris: Big Tobacco With High-Growth Smoke-Free Assets - Premium Price Tag
25.08.2026 10:46
Philip Morris Buy: premium pricing power, IQOS & ZYN driving 41%+ smoke-free revenue, and strong FCF/dividend growth. Click for more on PM stock.
Philip Morris International (PM) Gets New ZYN Clearance, Is The 8% Discount Still There?
22.08.2026 12:08
Philip Morris International (PM) drew fresh attention after the U.S. Food and Drug Administration granted Marketing Granted Orders for 11 ZYN ULTRA moist oral nicotine pouch products sold by its affiliate Swedish Match USA. See our latest analysis for Philip Morris International. At a share price of US$188.23, Philip Morris International has seen short term share price weakness, with the 30 day share price return declining 3.12%, while its year to date share price return of 17.42% and five...
Philip Morris International (PM) Stock Fair Value Edges Higher On IQOS And ZYN Optimism
22.08.2026 10:08
The fair value estimate for Philip Morris International has been updated from US$193.14 to US$203.80, indicating a slightly higher implied price target range. That change is consistent with recent analyst commentary that considers ongoing IQOS and ZYN execution, the resilience of combustibles, and mixed views on 2026 risks and currency pressure. Read on to see how this evolving narrative could influence your view of Philip Morris International and how to track future developments in the...
Wall Street's Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields
20.08.2026 07:14
In uncertain markets, investors look to dividend-yielding stocks. Benzinga's Analyst Stock Ratings page helps track top analysts' takes on high-yield consumer staples stocks. Accurate analysts rate HSY, PM, and MDLZ as buys.
Can Altria's Smoke-Free Push Finally Drive Long-Term Growth?
10.08.2026 14:34
MO's smoke-free push gains traction as on! PLUS expands distribution, retail share and product choice in a growing nicotine pouch category.
Philip Morris International (PM) Opens Its Largest US Manufacturing Campus For ZYN
05.08.2026 15:11
Philip Morris International opened a new manufacturing campus in Aurora, Colorado, its largest investment in the U.S. to date. The facility expands domestic production capacity for modern nicotine products, including nicotine pouches sold under the ZYN brand. The Aurora campus is fully integrated, supporting production, logistics, and distribution for the company’s U.S. operations. For investors tracking Philip Morris International, NYSE:PM, the Aurora opening adds context to a stock that...
Philip Morris International (PM) Faces Brazil Lawsuit Pressure, Is The Upside Already Priced In?
05.08.2026 09:19
Philip Morris International (NYSE:PM) is back in focus after Brazil’s landmark public health lawsuit moved a step closer to a liability ruling, putting long running legal risks alongside fresh investment and earnings data. See our latest analysis for Philip Morris International. The share price of Philip Morris International has pulled back in the past week with a 7 day share price return of 6.6% in the red, even after a 90 day share price return of 9.6% and a 1 year total shareholder return...
Altria Stock Trades Below The Market On Earnings And Above It On Sales
31.07.2026 14:51
Both readings are true at once, and the gap between them is the real question for anyone weighing the shares.
Altria Group (MO): A Winner in President Trump’s Stock Portfolio?
28.07.2026 14:23
Altria Group (NYSE:MO) sells cigarettes, oral nicotine pouches, and vapor products to adult tobacco users in the US. It’s the parent of Marlboro, still the country’s top-selling cigarette brand. The stock showed up in Donald Trump’s disclosed portfolio, and it’s easy to see the appeal: over 50 straight years of dividend increases and a business […]
Philip Morris International (PM) Wins FDA Modified Risk Status For ZYN In The US
26.07.2026 04:17
FDA authorizes Philip Morris International's ZYN nicotine pouches as modified risk tobacco products in the US. ZYN becomes the first and only smoke free nicotine pouch with this regulatory status in the US market. The decision recognizes PMI's harm reduction science and sets a new benchmark for smoke free alternatives. Philip Morris International (NYSE:PM) is expanding its smoke free portfolio, and the FDA's modified risk approval for ZYN puts a fresh spotlight on that shift. The company...
Is Philip Morris International (PM) Fairly Valued After Its 5 Year Run?
25.07.2026 04:19
Philip Morris International stock has delivered a very strong 143.6% total return over the past 5 years, yet current valuation checks and an intrinsic value estimate that sits close to the market price suggest the shares no longer look obviously cheap or clearly stretched either. A 143.6% return over 5 years highlights how much value the market has already priced into Philip Morris International, which naturally raises the bar for any further gains. Expectations around the growth and...
Four Stocks Hit New Highs Amid Tech Meltdown
24.07.2026 16:55
Halozyme Therapeutics is at a new high on Friday with earnings due on Aug. 6. Philip Morris International and KeyCorp are also at highs.
2 Cash-Producing Stocks on Our Buy List and 1 We Ignore
24.07.2026 11:29
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Philip Morris: The Warnings In The Robust Performance (Rating Downgrade)
24.07.2026 10:52
Philip Morris stock is downgraded to "Hold" as valuations are stretched and forecasts limit upside. Here's what investors need to know about PM.
Philip Morris: The First $11 Billion Quarter Won't Be The Last
23.07.2026 08:30
Philip Morris International delivered record Q2 2026 net revenues of $11.19 billion, with 15.2% adjusted EPS growth and expanding margins. Learn more about PM stock here.
Alphabet To Rally Around 39%? Here Are 10 Top Analyst Forecasts For Thursday
23.07.2026 08:02
Top analysts changed outlook on top names. Rosenblatt cut PEGA, Keefe boosted FBP, Needham raised PM, Jefferies increased VRSK, B of A cut ROL, Evercore cut ZION, Pivotal raised GOOGL, Barclays boosted TNL.